Skip to main content

Abstract

Bariatric surgery is recognized worldwide as a cost-effective treatment for morbidly obese patients. In recent years, the role of these procedures has been revised following the impressive postoperative outcomes from a metabolic and functional viewpoint. These outcomes have given rise to further possible indications for bariatric procedures that could be applied to non-obese patients in the near future. This chapter summarizes the evidence collected following bariatric procedures, both in terms of weight loss and remission of co-morbidities. We still need to clarify the concepts of “ideal weight” and “success” in bariatric surgery and moreover the exact interaction between gut hormones, pancreatic endocrine function and adipose cell signaling needs further investigations to predict a possible outcome or a possible relapse of a metabolic condition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hippocrates. Hippocrates (trans: Jones WHS). London/Cambridge: William Heinemann LTD/Harvard University Press; 1923.

    Google Scholar 

  2. Galeni C, Kalbfleisch K. Galeni De victu attenuante liber. Greek, Ancient [to 1453]. Lipsiae: In Aedibus B.G. Teubneri; 1898.

    Google Scholar 

  3. Alighieri D. The divine comedy, Canticle 6, third circle, The Gluttonous (trans: Longfellow HW). New York: Random House Publishing Group; 2003.

    Google Scholar 

  4. Moshiri M, Osman S, Robinson TJ, Khandelwal S, Bhargava P, Rohrmann CA. Evolution of bariatric surgery: a historical perspective. AJR Am J Roentgenol. 2013;201(1):W40–8.

    Article  PubMed  Google Scholar 

  5. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H et al.; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.

    Google Scholar 

  6. Shah B, Sucher K, Hollenbeck CB. Comparison of ideal body weight equations and published height-weight tables with body mass index tables for healthy adults in the United States. Nutr Clin Pract. 2006;21(3):312–9.

    Article  PubMed  Google Scholar 

  7. Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17(7):565–8.

    Article  PubMed  Google Scholar 

  8. Reinhold RB. Critical analysis of long term weight loss following gastric bypass. Surg Gynecol Obstet. 1982;155(3):385–94.

    CAS  PubMed  Google Scholar 

  9. Christou NV, Look D, McLean LD. Weight gain after short and long limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244(5):734–40.

    Article  PubMed Central  PubMed  Google Scholar 

  10. O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87–94.

    Article  PubMed  Google Scholar 

  11. Pérez-Romero N, Serra A, Granada ML, Rull M, Alastrué A, Navarro-Díaz M, et al. Effects of two variants of Roux-en-Y Gastric bypass on metabolism behaviour: focus on plasma ghrelin concentrations over a 2-year follow-up. Obes Surg. 2010;20(5):600–9.

    Article  PubMed  Google Scholar 

  12. Mason EE. Surgical treatment of obesity. Major Probl Clin Surg. 1981;26:26–480.

    Google Scholar 

  13. Mason EE, Culen JJ. Management of complications in vertical banded gastroplasty. Curr Probl Surg. 1997;7:359–62.

    Google Scholar 

  14. Melissas J, Leventi A, Klinaki I, Perisinakis K, Koukouraki S, de Bree E, et al. Alterations of global gastrointestinal motility after sleeve gastrectomy: a prospective study. Ann Surg. 2013;258(6):976–82.

    Article  PubMed  Google Scholar 

  15. Ma X, Lin L, Yue J, Pradhan G, Qin G, Minze LJ, et al. Ghrelin receptor regulates HFCS-induced adipose inflammation and insulin resistance. Nutr Diabetes. 2013;3, e99.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Clinical Issues Committee ASMBS. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2012;8(3):e21–6.

    Article  Google Scholar 

  17. Aurora AR, Khaitan L, Saber AA. Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients. Surg Endosc. 2012;26(6):1509–15.

    Article  PubMed  Google Scholar 

  18. Gagner M, Buchwald JN. Comparison of laparoscopic sleeve gastrectomy leak rates in four staple line reinforcement options: a systematic review. Surg Obes Relat Dis. 2014;10(4):713–23.

    Article  PubMed  Google Scholar 

  19. Van de Vrande S, Himpens J, El Mourad H, et al. Management of chronic proximal fistulas after sleeve gastrectomy by laparoscopic Roux limb placement. Surg Obes Relat Dis. 2013;9(6):856–61.

    Article  PubMed  Google Scholar 

  20. Burgerhart JS, Schotborgh CA, Schoon EJ, et al. Effect of sleeve gastrectomy on gastroesophageal reflux. Obes Surg. 2014;24(9):1436–41.

    Article  PubMed  Google Scholar 

  21. Mahawar KK, Jennings N, Balupuri S, et al. Sleeve gastrectomy and gastro-oesophageal reflux: a complex relationship. Obes Surg. 2013;23(7):987–91.

    Article  PubMed  Google Scholar 

  22. Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases.Obes Surg. 2001;11(3):276–80.

    Google Scholar 

  23. Lee WJ, Yu PJ, Wang W, Chen TC, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242(1):20–8.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Sudan R, Jacobs DO. Biliopancreatic diversion with duodenal switch. Surg Clin North Am. 2011;91(6):1281–93.

    Article  PubMed  Google Scholar 

  25. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.

    Article  PubMed  Google Scholar 

  26. Sjöström L. Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond). 2008;32 Suppl 7:S93–7.

    Article  Google Scholar 

  27. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.

    Article  PubMed  Google Scholar 

  28. Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care. 2013;36(1):20–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Yang J, Feng X, Zhong S, Wang Y, Liu J. Gastric bypass surgery may improve beta cell apoptosis with ghrelin overexpression in patients with BMI ≥32.5 kg/m2. Obes Surg. 2014;24(4):561–71.

    Article  CAS  PubMed  Google Scholar 

  30. Kario K. Obstructive sleep apnea syndrome and hypertension: ambulatory blood pressure. Hypertens Res. 2009;32(6):428–32.

    Article  PubMed  Google Scholar 

  31. Krieger D, Landsberg L. Mechanisms in obesity-related hypertension: role of insulin and catecholamines. Am J Hypertens. 1988;1(1):84–90.

    CAS  PubMed  Google Scholar 

  32. Karaca Ü, Schram MT, Houben AJ, Muris DM, Stehouwer CD. Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. Diab Res Clin Pract. 2014;103(3):382–7.

    Article  CAS  Google Scholar 

  33. Karlsson J, Sjöström L, Sullivan M. Swedish obese subjects (SOS)—an intervention study of obesity. Two-year follow-up of health related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes (Lond). 1998;22(2):113–26.

    Article  CAS  Google Scholar 

  34. The global challenge of obesity and the international obesity task force [Internet]. 2012. [Updated 2014 July 25; cited]. Available from: http://www.iuns.org/the-global-challenge-of-obesity-and-the-international-obesity-task-force.

  35. Quality and outcomes framework (QOF) 2011 [Internet]. 2011 [cited]. Available from: England: http://bit.ly/qof2011e,Northern Ireland: http://bit.ly/qof2011ni, Scotland: http://bit.ly/qof2011s, Wales: http://bit.ly/qof2011w.

  36. Khwaja HA, Brethauer SA, Schauer PR. Bariatric surgery for type 2 diabetes mellitus. In: Murayama KM, Chand B, Kothari SN, Mikami D, Nagle A (eds) Evidence-based approach to minimally invasive surgery. CInt-Med. 2012.

    Google Scholar 

  37. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256.e5.

    Article  PubMed  Google Scholar 

  38. Klein S, Ghosh A, Cremieux PY, Eapen S, McGavock TJ. Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI ≥35 kg/m2. Obesity (Silver Spring). 2011;19(3):581–7.

    Article  Google Scholar 

  39. Bolen SD, Chang HY, Weiner JP, Richards TM, Shore AD, Goodwin SM, et al. Clinical outcomes after bariatric surgery: a five-year matched cohort analysis in seven US states. Obes Surg. 2012;22(5):749–63.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.

    Article  CAS  PubMed  Google Scholar 

  42. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.

    Article  CAS  PubMed  Google Scholar 

  43. Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704.

    Article  CAS  PubMed  Google Scholar 

  44. Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Dixon JB, Zimmet P, Alberti KG, Rubino F; on behalf of the International Diabetes federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med. 2011;28(6):628–42.

    Google Scholar 

  46. American Diabetes Association. ASMBS Clinical Issues Committee. Bariatric surgery in class I obesity (BMI 30–35 kg/m2). Surg Obes Relat Dis 2013;9(1):e1–10.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luca Leuratti MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Leuratti, L., Khwaja, H.A., Kerrigan, D.D. (2016). Evidence Base for Bariatric Surgery. In: Agrawal, S. (eds) Obesity, Bariatric and Metabolic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-04343-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-04343-2_7

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-04342-5

  • Online ISBN: 978-3-319-04343-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics